TDFCX | VIVIX | TDFCX / VIVIX | |
Total Expense Ratio | 1.90 | 0.04 | 4,750% |
Annual Report Gross Expense Ratio | 1.95 | 0.04 | 4,875% |
Fund Existence | 13 years | 27 years | - |
Gain YTD | 5.997 | 6.548 | 92% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 194M | 196B | 0% |
Annual Yield % from dividends | 0.31 | 2.19 | 14% |
Returns for 1 year | 1.68 | 7.59 | 22% |
Returns for 3 years | 16.60 | 27.04 | 61% |
Returns for 5 years | 19.39 | 70.23 | 28% |
Returns for 10 years | -31.06 | 127.45 | -24% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FSSAX | 25.90 | 0.10 | +0.39% |
Franklin Small Cap Growth Adv | |||
SESVX | 22.97 | 0.09 | +0.39% |
SEI Small Cap Value F (SIMT) | |||
GFVAX | 15.83 | 0.01 | +0.06% |
Goldman Sachs Focused Value A | |||
PCUZX | 64.88 | 0.02 | +0.03% |
T. Rowe Price U.S. Equity Research Z | |||
UGTIX | 28.79 | -0.03 | -0.10% |
Victory Growth and Tax Strategy Ins |